Army, United States
Records under this name other than the patents Army, United States holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,148,130 | T4 Bacteriophage Bound to a Substrate Formerly held In force · High confidence | In force | High confidence | |
| US 7,722,889 | Plasmodium Liver Stage Antigens Formerly held Term ended Term ended Oct 3, 2026 · High confidence | Term ended | Term ended Oct 3, 2026 | High confidence |
| US 7,507,196 | Antisense antiviral compounds and methods for treating a filovirus infection Formerly held Term ended Term ended Oct 31, 2025 · USPTO record | Term ended | Term ended Oct 31, 2025 | USPTO record |
| US 7,494,980 | Antimicrobial Peptide and Methods of Use Thereof Term ended Term ended Mar 25, 2025 · High confidence | Term ended | Term ended Mar 25, 2025 | High confidence |
| US 6,988,394 | Apparatus and method of portable automated biomonitoring of water quality Term ended Term ended Feb 3, 2024 · USPTO record | Term ended | Term ended Feb 3, 2024 | USPTO record |
| US 7,407,935 | Ricin toxin A-chain fragment for use as a vaccine Term ended Term ended Jun 28, 2023 · USPTO record | Term ended | Term ended Jun 28, 2023 | USPTO record |
| US 7,015,036 | Human liver cell line Term ended Term ended Mar 30, 2023 · USPTO record | Term ended | Term ended Mar 30, 2023 | USPTO record |
| US 7,837,472 | Neurocognitive and psychomotor performance assessment and rehabilitation system Formerly held Term ended Term ended Dec 27, 2022 · USPTO record | Term ended | Term ended Dec 27, 2022 | USPTO record |
| US 6,875,433 | Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein Term ended Term ended Nov 13, 2022 · USPTO record | Term ended | Term ended Nov 13, 2022 | USPTO record |
| US 7,790,186 | Plasmodium vivax hybrid circumsporozoite protein and vaccine Lapsed on the fee record Ended Sep 7, 2022 · USPTO record | Lapsed on the fee record | Ended Sep 7, 2022 | USPTO record |